BioCorRx raises $600k from directors via stock and warrants; converts $314k note to equity

BioCorRx Inc.

Directors Galligan and Lucido each invest $300k at $1.75/share, receive warrants for equal shares at $4.00.
Lucido exchanges $313,892 promissory note for 183,606 shares of common stock, canceling the note.
Total shares issued: 342,592 from subscriptions plus 183,606 from note exchange = 526,198 shares.
Warrants exercisable for 3 years at $4.00 per share, issued to both directors.
Securities issued in private placement exempt from registration under Section 4(a)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.